ED CAHILL, PARTNER

Ed joined HLM as a partner in 2000. He was a founding partner of Cahill, Warnock & Company (now Camden Partners), a Baltimore venture capital firm, and a Managing Director of Alex. Brown & Sons, where he headed the firm’s Healthcare group from 1986 to 1995. During his leadership at Alex. Brown & Sons, he and his team underwrote public offerings or provided merger advisory services for over 200 healthcare companies, including the first publicly-held managed care, outpatient surgery center, rehabilitation, behavioral health and digital health companies and numerous pioneering biopharmaceutical and medical technology innovators.

Ed is a director of Blue Rabbit, Carevive Systems, Persivia, and Phreesia (NYSE:PHR). He is an observer for Aktana, and a Special Adviser to DermTech (NaSDaQ: DMTK). He previously served as a director of numerous companies, including Animas Corporation (acquired by J&J), Centene Corporation (NYSE), Masimo Corporation (NASDAQ), Tandem Diabetes (NASDAQ), TYRX (acquired by Medtronic) and Vets First Choice (now Covetrus : NASDAQ:CVET).

He is a Trustee of Mercy Health Services and a Trustee Emeritus of Johns Hopkins Medicine and Johns Hopkins Health System.

Ed received an AB from Williams College and a Master of Public and Private Management degree from Yale University. He lives with his wife, Kate, in Dedham, Massachusetts.